These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2934906)

  • 41. Alterations of Immune and Keratinization Gene Expression in Papulopustular Rosacea by Whole Transcriptome Analysis.
    Shih YH; Xu J; Kumar A; Li R; Chang ALS
    J Invest Dermatol; 2020 May; 140(5):1100-1103.e4. PubMed ID: 31705873
    [No Abstract]   [Full Text] [Related]  

  • 42. Ocular rosacea.
    Jenkins MS; Brown SI; Lempert SL; Weinberg RJ
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):189-95. PubMed ID: 6224068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
    Palamanda JR; Hickman D; Ward A; Sim E; Romkes-Sparks M; Unadkat JD
    Drug Metab Dispos; 1995 Apr; 23(4):473-7. PubMed ID: 7600914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [N-acetyltransferase and the process of adhesion formation in the abdominal cavity under experimental conditions].
    Magalashvili RD
    Khirurgiia (Mosk); 1985 Apr; (4):64-8. PubMed ID: 4010199
    [No Abstract]   [Full Text] [Related]  

  • 45. In vitro analysis of histone acetyltransferase activity.
    Benson LJ; Annunziato AT
    Methods; 2004 May; 33(1):45-52. PubMed ID: 15039086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation.
    Oyama T; Kawamoto T; Mizoue T; Yasumoto K; Kodama Y; Mitsudomi T
    Anticancer Res; 1997; 17(1B):577-81. PubMed ID: 9066583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
    De Leon JH; Martell KJ; Vatsis KP; Weber WW
    Drug Metab Dispos; 1995 Dec; 23(12):1354-61. PubMed ID: 8689943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphangiogenesis and angiogenesis in non-phymatous rosacea.
    Gomaa AH; Yaar M; Eyada MM; Bhawan J
    J Cutan Pathol; 2007 Oct; 34(10):748-53. PubMed ID: 17880579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Enzymatic acetylation of xenobiotics: its efficacy and role in side effects].
    Oganesian ET; Tvorovskiĭ DE; Mutsueva SKh
    Bioorg Khim; 1999 Aug; 25(8):603-10. PubMed ID: 10578466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Quality of life in patients with rosacea].
    Salamon M; Chodkiewicz J; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2008; 65(9):385-9. PubMed ID: 19140386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Frequency, severity and treatment of ocular rosacea during cutaneous rosacea].
    Michel JL; Cabibel F
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):20-4. PubMed ID: 12605152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulfadimidine acetylation in Norwegians. Comparison of sulfadimidine metabolism in Lapps, North Norwegians and South Norwegians.
    Olsen H; Mørland J
    Acta Med Scand; 1981; 210(1-2):119-24. PubMed ID: 7293820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The biochemical indices of genetic susceptibility to cancer. Acetylation phenotype and bladder cancer.
    Hanke J; Krajewska B
    Pol J Occup Med; 1988; 1(4):306-11. PubMed ID: 2979565
    [No Abstract]   [Full Text] [Related]  

  • 54. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
    Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rosacea in a monozygotic twin.
    Palleschi GM; Torchia D
    Australas J Dermatol; 2007 May; 48(2):132-3. PubMed ID: 17535206
    [No Abstract]   [Full Text] [Related]  

  • 56. A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process.
    Aroni K; Tsagroni E; Kavantzas N; Patsouris E; Ioannidis E
    Arch Dermatol Res; 2008 Mar; 300(3):125-31. PubMed ID: 18071725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
    Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Gastric acid secretion and mucosal morphology in rosacea].
    Drunkenmölle R; Schulz U
    Dermatologica; 1970; 141(6):385-92. PubMed ID: 4251353
    [No Abstract]   [Full Text] [Related]  

  • 60. [Acetylating capacity of the organism in patients with Itsenlo-Cushing disease].
    Vasiukova EA; Burduli MI; Ias'ko AA; Skvortsova RI
    Ter Arkh; 1973 Sep; 45(9):16-9. PubMed ID: 4756526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.